Resistance-associated substitutions and response to treatment in a chronic hepatitis C virus infected-patient: an unusual virological response case report

Background: Direct-Acting agents (DAAs) target and inhibit essential viral replication proteins. They have revolutionized the treatment of Hepatitis C virus (HCV) infection reaching high levels of sustained virologic response. However, the detection of basal resistance-associated substitutions (RASs...

Descrición completa

Detalles Bibliográficos

Autor Principal:	Aldunate Caramori, Fabián (author)
Outros autores:	Echeverría Chagas, Natalia (author), Chiodi, Daniela (author), López, Pablo (author), Sánchez-Cicerón, Adriana (author), Soñora, Martín (author), Cristina, Juan (author), Moratorio, Gonzalo (author), Hernández, Nelia (author), Moreno Karlen, María del Pilar (author)
Formato:	article
Idioma:	inglés
Publicado:	2021
Subjects:	DAA therapy Hepatitis C virus RASs minority variants Relapse Case report
Acceso en liña:	https://hdl.handle.net/20.500.12008/35752
Tags:	Engadir etiqueta Sen Etiquetas, Sexa o primeiro en etiquetar este rexistro!